Le Lézard
Classified in: Health
Subjects: CCA, CHI, LAW, FVT

Legal Team Led by Robert F. Kennedy, Jr. Sues New York State on Behalf of Families for Denying Lawful Medical Exemptions to School Children


ALBANY, N.Y., July 28, 2020 /PRNewswire/ -- Attorneys Sujata Gibson, Michael H. Sussman, Robert F. Kennedy, Jr. and Mary Holland filed a class action lawsuit last Thursday in Federal Court challenging the constitutionality of New York State's Department of Health regulations that allow school principals to overrule treating physicians on recommendations about medical exemptions to immunization for medically fragile kids. The named plaintiffs, eight New York State families whose valid medical exemptions for their school children were overruled, and Children's Health Defense (CHD) ask that the court declare the policy unconstitutional and allow children back into school.

"What these families have gone through shocks the conscience," said lead attorney Sujata Gibson. "Since the regulation took effect in August 2019, thousands of immunocompromised children in New York have had their treating physicians overruled and been removed from school."

In powerful detail, the complaint describes how these families have sought and received multiple exemptions from physicians and specialists, only to have them denied by school officials with no medical training. This widespread practice of rejecting valid medical exemptions is especially bewildering as New York repealed the religious exemption to vaccination in June 2019, arguing that it was to protect immunocompromised and medically vulnerable children.

"My child has suffered enough because of his health condition," said plaintiff Jane Doe. "Why must he suffer school expulsion and ostracism too?" Treating physicians assert that the policies are preventing them from doing their jobs: "Physicians who are on the ground, caring for these medically vulnerable children, need to be able to defend children's health without fear of professional and personal threats," said Lawrence B. Palevsky, MD.

Robert F. Kennedy, Jr., CHD Chairman, stated, "The right to a valid medical exemption from vaccine mandates has been federal law and policy for over 100 years. New York betrays children when it rejects exemptions from licensed, treating physicians in favor of the say-so of principals and superintendents."

During the press conference, lawyers will take questions from the media and concerned citizens. Register to receive a link to the press conference.

Contact: Sujata Gibson 
(607) 327-3284

SOURCE Children's Health Defense


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: